Gaudium IVF and Women Health Limited, a leading fertility and women’s healthcare provider in India, announced its financial performance for the quarter and nine months ended 31 December 2025. Source: BSE

Financial Performance: Key Details

Revenue from operations stood at ₹2,450.70 lakh in Q3 FY 2026 as compared to ₹1,442.50 lakh for Q3 FY 2025, up 70% y-o-y (down 23 percent Q-o-Q)

Total income was ₹2,461.00 lakh for Q3 FY 2026 as against ₹1,442.50 lakh for Q3 FY 2025.

Profit Before Tax (PBT) was ₹496.31 lakh in Q3 FY 2026 vs ₹469.32 lakh in Q3 FY 2025

Net Profit for Q3 FY 2026 stood at ₹363.05 lakh as compared to ₹339.77 lakh in Q3 FY 2025, up 6.77% y-o-y (down 61 percent Q-o-Q)

The Company maintained healthy margins during the period, supported by operating leverage and disciplined cost management.

Gaudium IVF and Women Health Q3 FY 2026

Management Speech –

Commenting on financial performance, Dr. Manika Khanna, Chairperson and Managing Director, Gaudium IVF and Women Health Limited, said

This is not just a quarter of strong performance, it reflects a category that is coming of age, and Gaudium IVF is at the forefront of shaping it.

Our listing marks a structural shift, from building a trusted clinical brand to institutionalising a scalable, future-ready healthcare platform.

We have been deliberate in how we grow, combining clinical excellence with operational discipline.

The opportunity in fertility care in India is significantly underpenetrated, and we see ourselves not just participating in this growth but leading it.

Our focus is clear, expand, access, deepen outcomes, and build India’s most trusted & outcome-driven fertility network.

Refer to gaudium ivf share news for further details.

The stock ended at INR 80.55 (down 15%) on the National Stock Exchange on Thursday, March 19, 2026.

ALSO READ: Central Mine Planning & Design Institute IPO Review

Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I (Vishal Dalwadi) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.

The post Gaudium IVF and Women Health Q3 FY 2026 appeared first on Upcoming ipos: Latest news on stocks, economy & finance.